Meno-Pause Peptide Pen – Ipamorelin + Sermorelin

A research-focused peptide formulation featuring two growth hormone-releasing peptides. – 10 mg, pre-filled 2.6 mL pen

The Meno-Pause Peptide Pen combines Ipamorelin and Sermorelin in a pre-filled 2.6 mL pen. These compounds are studied for their interactions with pathways involved in growth hormone signalling. The product is marketed toward age-related vitality and recovery research; however, claims that it balances hormones, burns fat, improves sleep or treats menopause symptoms have not been established for this specific product.

The pen has a stated total of 10 mg of active peptides and is supplied with six sterile needles. Its formulation, intended use, quality and regulatory status should be verified before publication or use.

Meno-Pause Peptide Pen Benefits & Key Features

• Dual-peptide formulation: Contains Ipamorelin and Sermorelin, stated at 5 mg each.
• Growth hormone pathway research: Both compounds are studied for their roles in growth hormone signalling.
• Pre-filled pen format: Supplied in a compact 2.6 mL presentation.
• Defined stated composition: 10 mg total peptide content according to the supplied product information.
• Supplied accessories: Includes six sterile needles; compatibility and intended use require confirmation.

These features describe the stated formulation and areas of research, not proven benefits for menopause, fat loss, muscle recovery, sleep or hormone balance.

Product Specifications

• Product name: Meno-Pause Pen
• Product type: Combined peptide formulation
• Peptides listed: Ipamorelin and Sermorelin
• Stated amount: 5 mg Ipamorelin + 5 mg Sermorelin
• Total stated active content: 10 mg
• Volume: 2.6 mL
• Stated clicks per pen: 240
• Supplied accessories: Six sterile needles
• Additional needles: Availability stated by supplier; confirm compatibility
• Supplier: Bio-Scientix Performance & Cosmetic Hub

Important Safety & Verification Notice

• Not a proven menopause treatment: The product name does not establish that this formulation treats menopause symptoms or balances hormones.
• Human-use status must be confirmed: Verify South African regulatory status, manufacturing standards, sterility, ingredients, concentration and whether the product is authorised for human administration.
• Do not use the supplied injection schedule as medical advice: The proposed dose, click count, timing and administration instructions have not been independently verified. Do not self-inject an unverified peptide formulation.
• Potential risks: Compounds affecting growth hormone pathways may carry risks, including changes in glucose regulation and fluid retention. The risks of this specific combination are not adequately established by the supplied information.
• Seek medical advice: Anyone with diabetes, a history of cancer, pituitary conditions, pregnancy or breastfeeding should consult a qualified healthcare professional before considering products that affect hormone pathways.
• Storage: The supplied information gives conflicting storage recommendations. Confirm the manufacturer’s validated storage conditions for this exact formulation.
• Keep out of reach of children. Do not use expired products or products with damaged packaging or an abnormal appearance.

Meno-Pause Peptide Pen is a stated 10 mg combined formulation containing 5 mg Ipamorelin and 5 mg Sermorelin in a 2.6 mL pre-filled pen with 240 stated clicks and six supplied sterile needles. Verify its regulatory status, quality, intended use and safety information before publication or use.